Should national pharmacare apply a value-based insurance design?
作者信息
Yeung Kai, Morgan Steven G
机构信息
Kaiser Permanente Washington Health Research Institute (Yeung), Seattle, Wash.; School of Population and Public Health (Morgan), The University of British Columbia, Vancouver, BC
Kaiser Permanente Washington Health Research Institute (Yeung), Seattle, Wash.; School of Population and Public Health (Morgan), The University of British Columbia, Vancouver, BC.
出版信息
CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721.
Abstract
摘要
相似文献
1
Should national pharmacare apply a value-based insurance design?国家药物保险计划是否应采用基于价值的保险设计？
CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721.
2
It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.实现全民医保并不容易：加拿大的经验。
Int J Health Policy Manag. 2020 Jan 1;9(1):1-5. doi: 10.15171/ijhpm.2019.82.
3
Federal budget disappoints on universal pharmacare.联邦预算在全民药物保险方面令人失望。
CMAJ. 2019 Apr 8;191(14):E406-E407. doi: 10.1503/cmaj.109-5736.
4
Addressing cost-related barriers to prescription drug use in Canada.解决加拿大与药品费用相关的用药障碍问题。
CMAJ. 2014 Mar 4;186(4):276-80. doi: 10.1503/cmaj.121637. Epub 2013 Sep 16.
5
Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.加拿大全民医保：医疗保健公平的一剂良药。
Int J Health Policy Manag. 2020 Mar 1;9(3):91-95. doi: 10.15171/ijhpm.2019.93.
6
Canada can afford universal pharmacare – no more excuses.加拿大有能力负担全民药物保险——别再找借口了。
CMAJ. 2015 Apr 21;187(7):475. doi: 10.1503/cmaj.150281. Epub 2015 Mar 23.
7
Canadian pharmacare: looking back, looking forward.加拿大药物保险计划：回顾与展望。
Healthc Policy. 2012 Aug;8(1):14-23.
8
Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.在加拿大现有公共药品计划中增加基本药物清单的全民公共覆盖的估计效果。
CMAJ. 2017 Feb 27;189(8):E295-E302. doi: 10.1503/cmaj.161082.
9
4 easy ways to cut your drug spending. Minimizing your prescription drug costs is easier than it may seem.削减药品开支的4种简单方法。将处方药费用降至最低比看起来要容易。
Harv Womens Health Watch. 2014 Nov;22(3):1, 7.
10
Pharmacare: Are we getting the right medicines?药物治疗：我们用的药对症吗？
Healthc Manage Forum. 2017 Jul;30(4):193-196. doi: 10.1177/0840470417696710.
引用本文的文献
1
A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.系统综述 umbrella review 处方药保险与费用分担与药物使用、卫生服务使用和健康的关联。
BMC Health Serv Res. 2022 Mar 3;22(1):297. doi: 10.1186/s12913-022-07554-w.
2
Who assigns value in value-based insurance design?在基于价值的保险设计中，谁来赋予价值？
CMAJ. 2020 Jan 6;192(1):E15. doi: 10.1503/cmaj.73617.
本文引用的文献
1
Price elasticities of pharmaceuticals in a value based-formulary setting.基于价值的药物处方集环境下的药品价格弹性。
Health Econ. 2018 Nov;27(11):1788-1804. doi: 10.1002/hec.3801. Epub 2018 Jul 20.
2
Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].汇总与决策方法——一种卫生经济学方法：一份ISPOR特别工作组报告[5]
Value Health. 2018 Feb;21(2):146-154. doi: 10.1016/j.jval.2017.12.010.
3
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].医疗保健价值的定义要素——一种卫生经济学方法：一份ISPOR特别工作组报告[3]
Value Health. 2018 Feb;21(2):131-139. doi: 10.1016/j.jval.2017.12.007.
4
Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.基于价值的处方集对药物使用、医疗服务利用及支出的影响。
Med Care. 2017 Feb;55(2):191-198. doi: 10.1097/MLR.0000000000000630.
5
France: Health System Review.法国：卫生系统评估
Health Syst Transit. 2015;17(3):1-218, xvii.
6
A randomized controlled trial of co-payment elimination: the CHORD trial.共付额消除的随机对照试验：CHORD试验。
Am J Manag Care. 2015 Aug;21(8):e455-64.
7
Design, implementation, and first-year outcomes of a value-based drug formulary.基于价值的药品处方集的设计、实施和第一年结果。
J Manag Care Spec Pharm. 2015 Apr;21(4):269-75. doi: 10.18553/jmcp.2015.21.4.269.
8
Interventions for enhancing medication adherence.提高药物依从性的干预措施。
Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4.
9
The h-e-B value-based health management program: impact on asthma medication adherence and healthcare cost.基于h-e-B价值的健康管理项目：对哮喘药物依从性和医疗保健成本的影响。
Am Health Drug Benefits. 2010 Nov;3(6):394-402.
10
Five features of value-based insurance design plans were associated with higher rates of medication adherence.基于价值的保险设计计划的五个特征与更高的药物依从率相关。
Health Aff (Millwood). 2014 Mar;33(3):493-501. doi: 10.1377/hlthaff.2013.0060. Epub 2014 Feb 12.
Zotero 插件